Skip to site menu Skip to page content

Daily Newsletter

08 August 2023

Daily Newsletter

08 August 2023

Royal Adelaide Hospital unveils Sip Til Send initiative for patients

The policy permits patients to consume clear liquids such as water, ice, diluted cordial, and black tea or coffee.

August 08 2023

Australia-based Royal Adelaide Hospital (RAH) has announced an initiative called Sip Til Send, allowing patients to drink fluids until their surgery commences.

This policy is expected to permit patients to consume clear liquids such as water, ice, diluted cordial, and black tea or coffee, sipping 200ml per hour.

Until their surgery, they will be able to sip these liquids every hour from a standard ward cup.

Sip Til Send was initially launched at Scotland's Ninewells Hospital and Medical School in 2021.

All Scottish Orthopaedic and Trauma centres, as well as multiple National Health Service (NHS) trusts, have adopted this approach.

RAH is the second Australian hospital to adopt this programme, following its launch at Sydney's Prince of Wales Hospital.

In contrast to the traditional pre-surgery protocols, some recent studies have proved that a controlled intake of fluids before surgery is safer, advantageous for patients and avoids the risk of aspiration.

In line with this, Sip Til Send claims to bring about enhanced patient hydration, overall well-being, and improved postoperative outcomes.

Notably, RAH patients will still be required to abstain from food for a duration of at least six hours prior to surgery, with exceptions made based on medical or surgical considerations.

Central Adelaide Local Health Network Surgery Program nurse lead Kristian Sanchez said: “The RAH is leading the way in South Australia, becoming the first hospital to ease strict liquid restrictions so surgery patients can now drink clear fluids right up until they go into theatre.

“We are working closely with the lead anaesthetist and nursing team for this project in Scotland to ensure we adopt this new policy as smoothly and effectively as possible.

“Fluid fasting can be uncomfortable so we hope this change will help ease our patient’s anxiety and prevent postoperative complications associated with dehydration.”

Healthcare companies are hesitant to invest in the metaverse

The COVID-19 pandemic pushed the healthcare industry to rapid digitalization. Increased use of telehealth, telepresence systems, remote diagnostics, predictive AI, and wearable technology is changing how healthcare is delivered and improving patient outcomes. Emerging technologies such as AR and VR are becoming increasingly routine for professional training, surgical assistance, and treatment of psychological and neurological disorders. In the pharma and medical devices industries, AR, VR, and AI are rapidly accelerating drug discovery and manufacturing and generating supply chain efficiencies. New digital opportunities will look to build upon disruptive technologies. However, affordability is a limiting factor to widespread adoption. Per GlobalData estimates, the metaverse market is expected to grow at a CAGR of more than 33% between 2023 and 2030. Although metaverse technologies could reinvent healthcare approaches and bring new experiences to healthcare providers and patients, adoption is still at an early stage. There are currently few use cases in the healthcare industry. The metaverse needs to overcome major challenges for healthcare, including regulation and data privacy concerns. Evidence of proven use cases and participation by a critical mass of users are imperative to drive a shift in metaverse investment.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close